BeWaRe: The New mRNA Flu Shots Will Likely Shed to Others

It s a dark day for MAHA. The U.S. FDA today approved the first messenger RNA (mRNA)-based seasonal flu shot, clearing the way for Moderna’s mFlusiva to be used in adults ages 50 and older, The New York Times reported. The approval is a major win for Moderna, which sees mFlusiva as the next step in expanding... Read More The post BeWaRe: The New mRNA Flu Shots Will Likely Shed to Others appeared…